Author Archives : Editorial Team

Home  >>  Author : Editorial Team

PEPperPRINT: GeneX India Bioscience Pvt. Ltd and PEPperPRINT sign distribution agreement for India

On February 22, 2018, Posted by , In News, With Comments Off on PEPperPRINT: GeneX India Bioscience Pvt. Ltd and PEPperPRINT sign distribution agreement for India

PEPperPRINT has signed a distribution agreement with GeneX India Bioscience Pvt. Ltd, covering marketing and sales rights for PEPperCHIP® Peptide Microarrays and PEPperMAP® Services in India. GeneX India BioScience was founded in the year 2004 as a distributor for biotech companies with focus on cell biology, molecular biology & proteomics…

EMBL: Insights into the evolution of a signalling molecule

On February 22, 2018, Posted by , In News, With Comments Off on EMBL: Insights into the evolution of a signalling molecule

 EMBL scientists discover how a molecule’s role changes from simple metabolite to instructive signal Retinoic acid signalling is crucial for the marine worm’s nervous system (green) to develop. IMAGE: Mette Handberg-Thorsager/EMBL Among developmental biologists, the signalling molecule retinoic acid is well known for its role in building the vertebrate body….

DKFZ: German Cancer Award for Michael Baumann

On February 22, 2018, Posted by , In News, With Comments Off on DKFZ: German Cancer Award for Michael Baumann

Michael Baumann, Chairman and Scientific Director of the German Cancer Research Center (DKFZ) in Heidelberg, receives the 2017 German Cancer Award in the category “Translational Research”. The science award, which is sponsored by the German Cancer Society and the German Cancer Foundation, is one of the most prestigious distinctions in…

AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases

On February 21, 2018, Posted by , In News, With Comments Off on AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases

Collaboration to include development of gene therapies consisting of vectors to deliver monoclonal antibodies to the brain directed against tau Voyager to receive $69 million upfront payment and potentially up to $155 million in preclinical and Phase 1 option payments as well as development and regulatory milestone payments and royalties…

DKFZ: Breast cancer: How advanced imaging technologies will help avoid unnecessary biopsies

On February 21, 2018, Posted by , In News, With Comments Off on DKFZ: Breast cancer: How advanced imaging technologies will help avoid unnecessary biopsies

Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent image analysis methods to detect malignant changes in tissues. This method may help avoid…

Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

On February 20, 2018, Posted by , In Press Releases, With Comments Off on Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

Researchers from Heidelberg University and TU Dresden, together with Intel Corporation, will reveal three new neuromorphic chips during the NICE Workshop 2018 in the USA. These chips have an extraordinary ability: They are able to mimic important aspects of biological brains by being energy efficient, resilient and able to learn….

DKFZ: European excellence grant for DKFZ researcher

On February 19, 2018, Posted by , In News, With Comments Off on DKFZ: European excellence grant for DKFZ researcher

The ERC Consolidator Grants by the European Research Council (ERC) support excellent researchers to help them consolidate their independent career. Ana Martin-Villalba from the German Cancer Research Center (DKFZ) has now received this prestigious ERC grant. Martin-Villalba will use the €2 million grant to investigate how repair processes can be…

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

On February 16, 2018, Posted by , In News, With Comments Off on Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

Acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of healthcare data and analytics The companies will leverage their combined expertise to advance the use of real-world evidence to set new industry standards for oncology research and development Flatiron Health to…

EMBL: Study identifies new diabetes genes

On February 15, 2018, Posted by , In News, With Comments Off on EMBL: Study identifies new diabetes genes

Scientists identify a network of genes that could play an important role in the development of diabetes Scientists used mice to identify 23 genes might play a role in human diabetes. PHOTO: EMBL-EBI/Spencer Phillips Researchers at the European Bioinformatics Institute (EMBL-EBI), with colleagues at the Helmholtz Center Munich and the…

DKFZ: “Lightning protectors” protect cells from oxidative damage

On February 15, 2018, Posted by , In News, With Comments Off on DKFZ: “Lightning protectors” protect cells from oxidative damage

Scientists from the German Cancer Research Center (DKFZ) have been able to unravel how acetylcysteine, a well-known agent used as a cough medication, can protect cells from oxidative stress. In the cell, the substance is rapidly transformed into so-called persulfides. These sulfur compounds unfold their protective effect on the cell…